Communiqués Strides Pharma Science Limited Bombay S.E.

Actions

STAR

INE939A01011

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:53 07/06/2024			Varia. 5j.	Varia. 1 janv.
883,4 ^INR	+0,51%		+2,48%	+36,25%

23/05	Strides Pharma Science enregistre un bénéfice net consolidé au quatrième trimestre fiscal ; les actions baissent de 3%.	MT
22/05	Transcript : Strides Pharma Science Limited, Q4 2024 Earnings Call, May 22, 2024

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Strides Pharma Science : Intimation of Board Meeting scheduled on May 22, 2024	14/05	PU
Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules	04/12	AQ
First African-Manufactured Combination Therapy For Seasonal Malaria Chemoprevention Receives WHO Prequalification [press release]	06/11	AQ
Strides Pharma Science : Intimation of Board Meeting scheduled on Sept 25, 2023	21/09/23	PU
Strides Pharma Science : Intimation of Board Meeting scheduled on August 2, 2023	26/07/23	PU
Strides Pharma Science : Intimation of Board Meeting scheduled on May 25, 2023	19/05/23	PU
Strides Pharma Science : Earnings Update_Q2FY23	09/02/23	PU
Strides Pharma Science : Earnings Update_Q3FY23	24/01/23	PU
Stelis Biopharma's flagship facility receives EIR from the USFDA on the successful closure of its inspection specific to Drug-Device Combination Products	19/01/23	AQ
Strides Pharma Science : Intimation of Board Meeting scheduled on January 24, 2023	17/01/23	PU
Strides Pharma Science : Share Warrants	16/09/22	PU
Stelis Biopharma's two biologics manufacturing facilities receive EU cGMP accreditation	16/06/22	AQ
Strides partners with Medicines Patent Pool (MPP) to commercialize the generic version of Pfizer's COVID-19 Oral Treatment across 95 markets	22/03/22	AQ
Akston Biosciences and Biolexis Collaborate to Launch a Room Temperature Stable 2nd Generation COVID-19 Vaccine in 130+ Countries	17/03/22	BU
Strides Pharma Science : Newspaper Advertisements	15/03/22	PU
Strides Pharma Science : Extra Ordinary Meeting	14/03/22	PU
Strides Pharma Science reports Q3 and 9M FY22 results	11/02/22	AQ
Strides Pharma Science : Preferential issue	10/02/22	PU
Strides Pharma Science : Results Deck Q3 FY22 10 Feb 2022	10/02/22	PU
Strides Pharma Science : Allotment of Securities	28/01/22	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Strides Pharma Science Limited Bombay S.E.

Actions

STAR

INE939A01011

Communiqués

Filtres